Literature DB >> 30742244

Radiologic parameters of ankylosing spondylitis patients treated with anti-TNF-α versus nonsteroidal anti-inflammatory drugs and sulfasalazine.

Seung Min Son1, Sung Hoon Choi1, Jong Ki Shin2, Tae Sik Goh2, Jung Sub Lee3.   

Abstract

PURPOSE: Limited data are available on the relationship between treatment agents and sagittal balance in ankylosing spondylitis (AS). We investigated radiological features related to treatment agents and compared sagittal balance between patients treated with anti-tumor necrosis factor-α (anti-TNF-α) and those treated with nonsteroidal anti-inflammatory drugs (NSAIDs) and sulfasalazine (SSZ).
METHODS: We prospectively enrolled 133 consecutive AS patients. Patients were eligible for the trial if they were under medical treatment with the same treatment agents for at least 1 year. All patients were treated initially with NSAIDs and SSZ. Sixty-nine patients achieved an excellent pain control outcome with these agents (group A). Sixty-four patients who reported of intractable low back pain were switched to anti-TNF-α treatment (group B). Twelve radiographic parameters were measured. Clinical outcome was assessed with the Bath AS Disease Activity Index (BASDAI), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). All parameters were measured at enrolment, upon changing treatment agents, and every 6 months during follow-up.
RESULTS: The mean ESR, CRP, BASDAI, and thoracic kyphosis at baseline were significantly higher in group B. After treatment, group B had significantly higher lumbar lordosis (LL) and significantly better clinical outcomes. Correlation analysis revealed significant relationships between radiologic parameters and BASDAI. On multiple regression analysis, LL was a significant predictor of BASDAI.
CONCLUSIONS: This study demonstrated a clear association between treatment agents and radiologic parameters in AS. Anti-TNF-α treatment improved LL with improvement in clinical outcomes. Lumbar lordosis was a significant predictor of clinical outcome in AS patients treated with anti-TNF-α. These slides can be retrieved under Electronic Supplementary Material.

Entities:  

Keywords:  Ankylosing spondylitis; Anti-TNF-α; Lumbar lordosis; Radiologic parameters; Sagittal balance

Mesh:

Substances:

Year:  2019        PMID: 30742244     DOI: 10.1007/s00586-019-05912-7

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  38 in total

1.  ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Authors:  J Zochling; D van der Heijde; R Burgos-Vargas; E Collantes; J C Davis; B Dijkmans; M Dougados; P Géher; R D Inman; M A Khan; T K Kvien; M Leirisalo-Repo; I Olivieri; K Pavelka; J Sieper; G Stucki; R D Sturrock; S van der Linden; D Wendling; H Böhm; B J van Royen; J Braun
Journal:  Ann Rheum Dis       Date:  2005-08-26       Impact factor: 19.103

Review 2.  How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured?

Authors:  Désirée van der Heijde; Robert Landewé; Sjef van der Linden
Journal:  Arthritis Rheum       Date:  2005-07

3.  Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept.

Authors:  X Baraliakos; J Davis; W Tsuji; J Braun
Journal:  Arthritis Rheum       Date:  2005-04

4.  Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system.

Authors:  J Braun; X Baraliakos; W Golder; J Brandt; M Rudwaleit; J Listing; M Bollow; J Sieper; D Van Der Heijde
Journal:  Arthritis Rheum       Date:  2003-04

5.  Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis.

Authors:  L Laloux; M C Voisin; J Allain; N Martin; L Kerboull; X Chevalier; P Claudepierre
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

6.  Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.

Authors:  M Rudwaleit; X Baraliakos; J Listing; J Brandt; J Sieper; J Braun
Journal:  Ann Rheum Dis       Date:  2005-03-18       Impact factor: 19.103

7.  Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging.

Authors:  M Bollow; T Fischer; H Reisshauer; M Backhaus; J Sieper; B Hamm; J Braun
Journal:  Ann Rheum Dis       Date:  2000-02       Impact factor: 19.103

8.  Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).

Authors:  Désirée van der Heijde; Ben Dijkmans; Piet Geusens; Joachim Sieper; Kimberly DeWoody; Paul Williamson; Jürgen Braun
Journal:  Arthritis Rheum       Date:  2005-02

9.  Anatomic structures involved in early- and late-stage sacroiliitis in spondylarthritis: a detailed analysis by contrast-enhanced magnetic resonance imaging.

Authors:  B Muche; M Bollow; R J François; J Sieper; B Hamm; J Braun
Journal:  Arthritis Rheum       Date:  2003-05

10.  Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.

Authors:  Jianxiang Zou; Martin Rudwaleit; Jan Brandt; Andreas Thiel; Jürgen Braun; Joachim Sieper
Journal:  Arthritis Rheum       Date:  2003-03
View more
  1 in total

Review 1.  The Michel Benoist and Robert Mulholland yearly European spine journal review: a survey of the "medical" articles in European spine journal, 2019.

Authors:  Michel Benoist
Journal:  Eur Spine J       Date:  2019-12-31       Impact factor: 3.134

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.